| [1] |
Alves CC, Carneiro F,Hoefler H,et al. Role of the epithelialmesenchymal transition regulator Slug in primary human cancers[J]. Front Biosci (Landmark Ed),2009,14:3035-3050.
|
| [2] |
刘怡茜, 郭人花, 刘连科, 等. 叉头框转录因子M1 在非小细胞癌中的表达及其与患者临床病理特征和生存的关系[J]. 中华肿瘤杂志,2011,33(6):426-430.
|
| [3] |
Liu T, Zhang X, Shang M, et al. Dysregulated expression of Slug, vimentin, and E-cadherin correlates with poor clinical outcome in patients with basal-like breast cancer[J]. J Surg Oncol,2013,107(2):188-194.
|
| [4] |
Mahler-Araujo B, Savage K, Parry S, et al. Reduction of E-cadherin expression is associated with non-lobular breast carcinomas of basal-like and triple negative phenotype[J]. J Clin Pathol,2008,61(5):615-620
|
| [5] |
侯铸, 罗勇, 赵佳晖, 等. EMT 标记蛋白在前列腺癌组织中的表达及其意义[J]. 中国男科学杂志, 2009, 23(12):21-24.
|
| [6] |
Yilmaz M, Christofori G. EMT, the cytoskeleton, and cancer cell invasion[J]. Cancer Metastasis Rev,2009,28(1-2):15-33.
|
| [7] |
Jiang J, Tang YL, Liang XH. EMT: a new vision of hypoxia promoting cancer progression[J]. Cancer Biol Ther, 2011,11(8):714-723.
|
| [8] |
Tiwari N, Gheldof A, Tatari M, et al. EMT as the ultimate survival mechanism of cancer cells[J]. Semin Cancer Biol,2012,22(3):194-207.
|
| [9] |
Hazan RB, Qiao R, Keren R, et al. Cadherin switch in tumor progression[J]. Ann N Y Acad Sci,2004,1014:155-163.
|
| [10] |
Maeda M, Johnson KR, Wheelock MJ. Cadherin switching:essential for behavioral but not morphological changes during an epithelium-to-mesenchyme transition[J]. J Cell Sci, 2005,118(5):873-887.
|
| [11] |
Sarrió D, Rodriguez-Pinilla SM, Hardisson D, et al.Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype[J]. Cancer Res,2008,68(4):989-997.
|
| [12] |
Li Q, Zhang N, Jia Z, et al. Critical role and regulation of transcription factor FoxM1 in human gastric cancer angiogenesis and progression[J]. Cancer Res,2009,69(4):3501-3509.
|
| [13] |
Gialmanidis IP, Bravou V, Amanetopoulou SG, et al.Overexpression of hedgehog pathway molecules and FOXM1 in non-small cell lung carcinomas[J]. Lung Cancer,2009,66(1):64-74.
|
| [14] |
Gusarova GA, Wang IC, Major ML, et al. A cell-penetrating ARF peptide inhibitor of FoxM1 in mouse hepatocellular carcinoma treatment[J]. Clin Invest,2007,117(1):99-111.
|
| [15] |
Park HJ, Gusarova G, Wang Z, et al. Deregulation of FoxM1b leads to tumor metastasis[J]. EMBO Mol Med, 2011, 3(1):21-34.
|
| [16] |
Bao B, Wang Z, Ali S, et al. Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells[J]. J Cell Biochem,2011,112(9):2296-2306.
|
| [17] |
Wang Z, Wade P, Mandell KJ, et al. Raf 1 represses expression of the tight junction protein occluding via activation of the zinc-finger transcription factor slug [J]. Oncogene,2007,26(8):1222-1230.
|
| [18] |
Suh Y, Yoon CH, Kim RK, et al. Claudin-1 induces epithelial-mesenchymal transition through activation of the c-Abl-ERK signaling pathway in human liver cells [ J].Oncogene,2013,32(41):4873-4882.
|
| [19] |
Huang CH, Yang WH, Chang SY, et al. Regulation of membrane-type 4 matrix metalloproteinase by SLUG contributes to hypoxia-mediated metastasis[J]. Neoplasia, 2009, 11(12):1371-1382.
|
| [20] |
Vega S, Morales AV, Ocaña OH, et al. Snail blocks the cell cycle and confers resistance to cell death[J]. Gene Dev,2004,18(10):1131-1143.
|
| [21] |
Yang C, Chen H, Tan G, et al. FOXM1 promotes the epithelial to mesenchymal transition by stimulating the transcription of Slug in human breast cancer[J]. Cancer Lett,2013,340 (1):104-112.
|